Ex-Merlin BioMed exec starts healthcare strat

Wed Jan 20, 2010

U.S. healthcare spending has increased from 4.5% of the GDP in 1950 to 16% in 2008, and yet infant mortality and life expectancy in the U.S. is still behind Western Europe, Japan, Australia and Canada.

Stuart Weisbrod, founder of the now-closed Merlin BioMed Group, recently formed Iguana Healthcare Partners and launched a long/short fund on Jan. 1.

Before founding Greenwich, Conn.-based Iguana in the fall of 2009, Weisbrod ran Merlin BioMed, a long/short healthcare-oriented hedge fund he founded in 1998 and closed in December 2007. He served as chief investment officer and the firm’s funds achieved a net annualized return of more than...

ISSN: 2151-1845 / CDC10004H


The full contents of this article are available to Absolute Return subscribers and trialists only.

To continue reading please, take a free trial, subscribe or log in.


Subscribers have unlimited access to all current and archive content. Start your subscription today - click on the button below.

Subscribe now

Popular Searches on HFI